Published in Proc Natl Acad Sci U S A on February 05, 2009
The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet (2010) 15.87
Dicer1 and miR-219 Are required for normal oligodendrocyte differentiation and myelination. Neuron (2010) 3.37
MicroRNA-mediated control of oligodendrocyte differentiation. Neuron (2010) 3.24
Striatal microRNA controls cocaine intake through CREB signalling. Nature (2010) 2.56
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov (2012) 2.44
Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol Psychiatry (2009) 2.16
Inhibition of microRNA function by antimiR oligonucleotides. Silence (2012) 2.02
MicroRNAs in neuronal function and dysfunction. Trends Neurosci (2012) 1.94
γCaMKII shuttles Ca²⁺/CaM to the nucleus to trigger CREB phosphorylation and gene expression. Cell (2014) 1.84
MicroRNAs shape the neuronal landscape. Neuron (2012) 1.64
Dicer ablation in oligodendrocytes provokes neuronal impairment in mice. Ann Neurol (2009) 1.62
MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia. PLoS One (2011) 1.47
Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines. Genome Med (2010) 1.41
A novel microRNA and transcription factor mediated regulatory network in schizophrenia. BMC Syst Biol (2010) 1.40
MicroRNA dysregulation in psychiatric disease. Brain Res (2010) 1.34
Glutamatergic model psychoses: prediction error, learning, and inference. Neuropsychopharmacology (2010) 1.34
Silencing of the miR-17~92 cluster family inhibits medulloblastoma progression. Cancer Res (2013) 1.28
Functions of noncoding RNAs in neural development and neurological diseases. Mol Neurobiol (2011) 1.27
MicroRNA networks direct neuronal development and plasticity. Cell Mol Life Sci (2011) 1.23
The Emerging Role of microRNAs in Schizophrenia and Autism Spectrum Disorders. Front Psychiatry (2012) 1.22
Circulating miRNA biomarkers for Alzheimer's disease. PLoS One (2013) 1.22
MicroRNAs in psychiatric and neurodevelopmental disorders. Brain Res (2010) 1.22
MicroRNAs show mutually exclusive expression patterns in the brain of adult male rats. PLoS One (2009) 1.16
Sequence-non-specific effects of RNA interference triggers and microRNA regulators. Nucleic Acids Res (2009) 1.11
MicroRNAs and deregulated gene expression networks in neurodegeneration. Brain Res (2010) 1.11
Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases. Cell Mol Neurobiol (2013) 1.09
MicroRNAs in mental health: from biological underpinnings to potential therapies. Neuromolecular Med (2009) 1.09
Converging miRNA functions in diverse brain disorders: a case for miR-124 and miR-126. Exp Neurol (2011) 1.04
MicroRNAs control neurobehavioral development and function in zebrafish. FASEB J (2012) 1.04
MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction. Neurobiol Dis (2012) 1.02
Maternal stress induces epigenetic signatures of psychiatric and neurological diseases in the offspring. PLoS One (2013) 1.00
Evidence for Alteration of Gene Regulatory Networks through MicroRNAs of the HIV-infected brain: novel analysis of retrospective cases. PLoS One (2010) 1.00
Expression of microRNAs and other small RNAs in prefrontal cortex in schizophrenia, bipolar disorder and depressed subjects. PLoS One (2014) 0.99
The Path to microRNA Therapeutics in Psychiatric and Neurodegenerative Disorders. Front Genet (2012) 0.98
Gender-specific reduction of estrogen-sensitive small RNA, miR-30b, in subjects with schizophrenia. Schizophr Bull (2010) 0.98
MicroRNA-382 expression is elevated in the olfactory neuroepithelium of schizophrenia patients. Neurobiol Dis (2013) 0.97
Non-coding RNA transcripts: sensors of neuronal stress, modulators of synaptic plasticity, and agents of change in the onset of Alzheimer's disease. Neurosci Lett (2009) 0.96
Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128. Mol Cancer (2014) 0.96
Emerging role of non-coding RNA in neural plasticity, cognitive function, and neuropsychiatric disorders. Front Genet (2012) 0.89
Memory acquisition and retrieval impact different epigenetic processes that regulate gene expression. BMC Genomics (2015) 0.89
Regulation of myelin genes implicated in psychiatric disorders by functional activity in axons. Front Neuroanat (2009) 0.88
Regulatory RNAs in brain function and disorders. Brain Res (2010) 0.87
MicroRNAs: Key Regulators in the Central Nervous System and Their Implication in Neurological Diseases. Int J Mol Sci (2016) 0.87
Impulsivity and comorbid traits: a multi-step approach for finding putative responsible microRNAs in the amygdala. Front Neurosci (2014) 0.87
Approaches to manipulating microRNAs in neurogenesis. Front Neurosci (2013) 0.87
Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations. BMC Genomics (2011) 0.86
Chronological changes in microRNA expression in the developing human brain. PLoS One (2013) 0.86
miR-155 is involved in Alzheimer's disease by regulating T lymphocyte function. Front Aging Neurosci (2015) 0.86
Non-coding RNAs--novel targets in neurotoxicity. Neurotoxicology (2012) 0.86
Epigenetics and ncRNAs in brain function and disease: mechanisms and prospects for therapy. Neurotherapeutics (2013) 0.85
Placental miRNA expression profiles are associated with measures of infant neurobehavioral outcomes. Pediatr Res (2013) 0.85
Glutamatergic transmission in drug reward: implications for drug addiction. Front Neurosci (2015) 0.84
Heterogeneity and individuality: microRNAs in mental disorders. J Neural Transm (Vienna) (2014) 0.84
MicroRNAs suggest a new mechanism for altered brain gene expression in schizophrenia. Proc Natl Acad Sci U S A (2009) 0.83
MicroRNAs in Neurotoxicity. J Toxicol (2012) 0.83
MicroRNA miR124 is required for the expression of homeostatic synaptic plasticity. Nat Commun (2015) 0.82
A microRNA negative feedback loop downregulates vesicle transport and inhibits fear memory. Elife (2016) 0.82
Plasticity-related microRNA and their potential contribution to the maintenance of long-term potentiation. Front Mol Neurosci (2015) 0.81
microRNAs as novel biomarkers of schizophrenia (Review). Exp Ther Med (2014) 0.81
Noncoding RNAs and neurobehavioral mechanisms in psychiatric disease. Mol Psychiatry (2015) 0.81
The TLX-miR-219 cascade regulates neural stem cell proliferation in neurodevelopment and schizophrenia iPSC model. Nat Commun (2016) 0.80
MicroRNA-572 improves early post-operative cognitive dysfunction by down-regulating neural cell adhesion molecule 1. PLoS One (2015) 0.80
microRNA-128a dysregulation in transgenic Huntington's disease monkeys. Mol Brain (2014) 0.80
Neuronal activity-dependent regulation of MicroRNAs. Mol Cells (2014) 0.80
Potential molecular and cellular mechanism of psychotropic drugs. Clin Psychopharmacol Neurosci (2014) 0.79
PEI-complexed LNA antiseeds as miRNA inhibitors. RNA Biol (2012) 0.79
Regulatory RNAs and control of epigenetic mechanisms: expectations for cognition and cognitive dysfunction. Epigenomics (2015) 0.79
A Genetic Variant in miRNA-219-1 Is Associated with Risk of Esophageal Squamous Cell Carcinoma in Chinese Kazakhs. Dis Markers (2015) 0.79
MicroRNA delivery for regenerative medicine. Adv Drug Deliv Rev (2015) 0.79
MicroRNA: implications in HIV, a brief overview. J Neurovirol (2011) 0.79
Sexually dimorphic effects of gestational endocrine-disrupting chemicals on microRNA expression in the developing rat hypothalamus. Mol Cell Endocrinol (2015) 0.79
Distinct roles of multiple isoforms of CaMKII in signaling to the nucleus. Biochim Biophys Acta (2015) 0.78
Generation of a neuro-specific microarray reveals novel differentially expressed noncoding RNAs in mouse models for neurodegenerative diseases. RNA (2014) 0.78
Associations between DNA methylation and schizophrenia-related intermediate phenotypes - a gene set enrichment analysis. Prog Neuropsychopharmacol Biol Psychiatry (2015) 0.78
Non-Coding RNAs as Potential Neuroprotectants against Ischemic Brain Injury. Brain Sci (2013) 0.77
microPIR2: a comprehensive database for human-mouse comparative study of microRNA-promoter interactions. Database (Oxford) (2014) 0.77
Role of MicroRNA in Visceral Pain. J Neurogastroenterol Motil (2015) 0.77
The Potential Role of Amygdaloid MicroRNA-494 in Alcohol-Induced Anxiolysis. Biol Psychiatry (2015) 0.77
Polymorphisms in MicroRNA Genes And Genes Involving in NMDAR Signaling and Schizophrenia: A Case-Control Study in Chinese Han Population. Sci Rep (2015) 0.77
Enriched environment prevents cognitive and motor deficits associated with postnatal MK-801 treatment. Psychopharmacology (Berl) (2014) 0.76
MicroRNA profiling of the whitefly Bemisia tabaci Middle East-Aisa Minor I following the acquisition of Tomato yellow leaf curl China virus. Virol J (2016) 0.76
Current perspectives on the neurobiology of drug addiction: a focus on genetics and factors regulating gene expression. ISRN Neurol (2012) 0.76
Interaction of drugs of abuse and microRNA with HIV: a brief review. Front Microbiol (2015) 0.76
Melatonin, noncoding RNAs, messenger RNA stability and epigenetics--evidence, hints, gaps and perspectives. Int J Mol Sci (2014) 0.76
Environmental Intervention as a Therapy for Adverse Programming by Ancestral Stress. Sci Rep (2016) 0.75
miR-196a Ameliorates Cytotoxicity and Cellular Phenotype in Transgenic Huntington's Disease Monkey Neural Cells. PLoS One (2016) 0.75
Advances in non-coding RNA profiling for neurological diseases. Front Genet (2013) 0.75
Association between single nucleotide polymorphisms in MiR219-1 and MiR137 and susceptibility to schizophrenia in a Chinese population. FEBS Open Bio (2015) 0.75
Diagnostic and therapeutic potential of microRNAs in neuropsychiatric disorders: Past, present, and future. Prog Neuropsychopharmacol Biol Psychiatry (2016) 0.75
MicroRNA-30 inhibits neointimal hyperplasia by targeting Ca(2+)/calmodulin-dependent protein kinase IIδ (CaMKIIδ). Sci Rep (2016) 0.75
The microRNA network is altered in anterior cingulate cortex of patients with unipolar and bipolar depression. J Psychiatr Res (2016) 0.75
MicroRNAs as Biomarkers for Psychiatric Conditions: A Review of Current Research. Innov Clin Neurosci (2017) 0.75
Preoperative Serum MicroRNA-155 Expression Independently Predicts Postoperative Cognitive Dysfunction After Laparoscopic Surgery for Colon Cancer. Med Sci Monit (2016) 0.75
Retinoic acid-induced upregulation of miR-219 promotes the differentiation of embryonic stem cells into neural cells. Cell Death Dis (2017) 0.75
Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol (2004) 15.15
LNA-mediated microRNA silencing in non-human primates. Nature (2008) 11.45
A brain-specific microRNA regulates dendritic spine development. Nature (2006) 10.18
Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science (2005) 8.20
Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol (2004) 7.33
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial. Nat Med (2007) 7.24
NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci (2007) 6.26
Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res (2007) 5.67
The neuronal microRNA system. Nat Rev Neurosci (2006) 5.38
How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev (2005) 5.22
Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell (1999) 4.93
microRNA modulation of circadian-clock period and entrainment. Neuron (2007) 4.49
Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells. J Cell Biol (1982) 3.85
Disruption of dendritic translation of CaMKIIalpha impairs stabilization of synaptic plasticity and memory consolidation. Neuron (2002) 3.78
Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. Neuroreport (2007) 3.70
microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol (2007) 3.26
Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc Natl Acad Sci U S A (2000) 3.04
The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatry (1997) 2.63
Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. Int Rev Neurobiol (2007) 2.57
Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology (2001) 2.49
The Elegance of the MicroRNAs: A Neuronal Perspective. Neuron (2005) 2.12
Somatodendritic microRNAs identified by laser capture and multiplex RT-PCR. RNA (2007) 2.01
Brain expressed microRNAs implicated in schizophrenia etiology. PLoS One (2007) 1.85
Development of a mouse test for repetitive, restricted behaviors: relevance to autism. Behav Brain Res (2007) 1.71
Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference. Proc Natl Acad Sci U S A (2004) 1.58
Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder. Neuropsychopharmacology (2007) 1.56
MicroRNA in schizophrenia: genetic and expression analysis of miR-130b (22q11). Biochemistry (Mosc) (2007) 1.41
Models of schizophrenia in humans and animals based on inhibition of NMDA receptors. Neurosci Biobehav Rev (2008) 1.35
MeCP2-dependent repression of an imprinted miR-184 released by depolarization. Hum Mol Genet (2008) 1.29
Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorder. Genes Brain Behav (2006) 1.24
siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain. Mol Psychiatry (2005) 1.23
Hypothesis: is infantile autism a hypoglutamatergic disorder? Relevance of glutamate - serotonin interactions for pharmacotherapy. J Neural Transm (Vienna) (1998) 1.21
Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors. Psychopharmacology (Berl) (1995) 1.11
Brief alteration of NMDA or GABAA receptor-mediated neurotransmission has long term effects on the developing cerebral cortex. Mol Cell Proteomics (2008) 1.07
Role reversal: the regulation of neuronal gene expression by microRNAs. Curr Opin Neurobiol (2005) 1.06
Dopamine and serotonin interactions in the prefrontal cortex: insights on antipsychotic drugs and their mechanism of action. Pharmacopsychiatry (2007) 0.95
Glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A) gene as a positional candidate for attention-deficit/hyperactivity disorder in the 16p13 region. Mol Psychiatry (2004) 0.93
NMDA receptor subunits in the postsynaptic density of rat brain: expression and phosphorylation by endogenous protein kinases. Brain Res Mol Brain Res (1998) 0.93
Effect of acute and chronic MK-801 administration on extracellular glutamate and ascorbic acid release in the prefrontal cortex of freely moving mice on line with open-field behavior. Life Sci (2005) 0.91
NMDA receptor function in the prefrontal cortex of a rat model for attention-deficit hyperactivity disorder. Metab Brain Dis (2004) 0.90
Participation of CaMKII in neuronal plasticity and memory formation. Cell Mol Neurobiol (2002) 0.88
The role of N-methyl-D-aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes. Eur Neuropsychopharmacol (1998) 0.87
MK-801 increases locomotor activity without elevating extracellular dopamine levels in the nucleus accumbens. Synapse (1996) 0.87
Amygdala-dependent regulation of electrical properties of hippocampal interneurons in a model of schizophrenia. Biol Psychiatry (2008) 0.86
Phencyclidine-induced increases in striatal neuron firing in behaving rats: reversal by haloperidol and clozapine. J Neural Transm Gen Sect (1995) 0.80
Genome-wide analysis of mammalian promoter architecture and evolution. Nat Genet (2006) 17.19
MicroRNA expression in zebrafish embryonic development. Science (2005) 15.52
LNA-mediated microRNA silencing in non-human primates. Nature (2008) 11.45
Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science (2009) 10.30
Treatment of HCV infection by targeting microRNA. N Engl J Med (2013) 9.91
microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci U S A (2006) 8.24
In situ detection of miRNAs in animal embryos using LNA-modified oligonucleotide probes. Nat Methods (2006) 6.67
The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line. Nat Genet (2009) 6.02
Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci (2010) 5.98
Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res (2007) 5.67
Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med (2008) 5.62
An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell (2005) 5.60
Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res (2007) 5.25
Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci U S A (2008) 5.24
RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain. RNA (2005) 4.91
Silencing of microRNA families by seed-targeting tiny LNAs. Nat Genet (2011) 4.81
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci U S A (2008) 4.79
Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron (2005) 4.78
Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages. Proc Natl Acad Sci U S A (2007) 4.69
Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci (2003) 4.50
Regulatory roles of natural antisense transcripts. Nat Rev Mol Cell Biol (2009) 4.48
Desensitization of G protein-coupled receptors and neuronal functions. Annu Rev Neurosci (2004) 4.44
Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res (2008) 4.20
Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A (2002) 4.20
Sensitive and specific detection of microRNAs by northern blot analysis using LNA-modified oligonucleotide probes. Nucleic Acids Res (2004) 3.97
miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol Ther (2007) 3.93
Habenular α5 nicotinic receptor subunit signalling controls nicotine intake. Nature (2011) 3.77
Complex Loci in human and mouse genomes. PLoS Genet (2006) 3.74
Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci U S A (2004) 3.60
In vitro degradation of silk fibroin. Biomaterials (2005) 3.56
Dishevelled 2 recruits beta-arrestin 2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4. Science (2003) 3.52
LNA-modified oligonucleotides mediate specific inhibition of microRNA function. Gene (2006) 3.49
A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis. Nat Cell Biol (2009) 3.44
The reality of pervasive transcription. PLoS Biol (2011) 3.41
Food reward in the absence of taste receptor signaling. Neuron (2008) 3.37
MicroRNA expression in the adult mouse central nervous system. RNA (2008) 3.12
Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation. Nat Biotechnol (2012) 3.07
Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci U S A (2005) 3.05
Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J Clin Invest (2010) 3.04
MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat Neurosci (2010) 3.00
Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev (2004) 2.97
Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet (2010) 2.95
MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest (2010) 2.87
RNAdb--a comprehensive mammalian noncoding RNA database. Nucleic Acids Res (2005) 2.84
Neurobiological evidence for hedonic allostasis associated with escalating cocaine use. Nat Neurosci (2002) 2.83
Detection of microRNAs in frozen tissue sections by fluorescence in situ hybridization using locked nucleic acid probes and tyramide signal amplification. Nat Protoc (2007) 2.80
Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res (2009) 2.80
Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity. Neuron (2004) 2.76
Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins. Prog Neurobiol (2002) 2.76
A beta-arrestin 2 signaling complex mediates lithium action on behavior. Cell (2008) 2.76
Using molecular classification to predict gains in maximal aerobic capacity following endurance exercise training in humans. J Appl Physiol (1985) (2010) 2.74
miR-200b mediates post-transcriptional repression of ZFHX1B. RNA (2007) 2.67
Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science (2004) 2.64
Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc Natl Acad Sci U S A (2003) 2.62
Akt/GSK3 signaling in the action of psychotropic drugs. Annu Rev Pharmacol Toxicol (2009) 2.60
Striatal microRNA controls cocaine intake through CREB signalling. Nature (2010) 2.56
Monoamine transporters: from genes to behavior. Annu Rev Pharmacol Toxicol (2002) 2.54
Exome sequencing of a multigenerational human pedigree. PLoS One (2009) 2.48
The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation. J Biol Chem (2002) 2.47
Building a new conceptual framework for receptor heteromers. Nat Chem Biol (2009) 2.41
The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice. J Clin Invest (2011) 2.30
A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites. Nucleic Acids Res (2005) 2.27
Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. Proc Natl Acad Sci U S A (2008) 2.23
The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends Pharmacol Sci (2007) 2.22
Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality. Nucleic Acids Res (2005) 2.20
Rapid alterations in corticostriatal ensemble coordination during acute dopamine-dependent motor dysfunction. Neuron (2006) 2.19
Uncovering growth-suppressive MicroRNAs in lung cancer. Clin Cancer Res (2009) 2.19
Exome sequencing allows for rapid gene identification in a Charcot-Marie-Tooth family. Ann Neurol (2011) 2.09
Evidence for natural antisense transcript-mediated inhibition of microRNA function. Genome Biol (2010) 2.08
MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc Natl Acad Sci U S A (2011) 2.05
Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice. Neuron (2003) 2.03
Inhibition of microRNA function by antimiR oligonucleotides. Silence (2012) 2.02
Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice. J Neurosci (2002) 2.01
Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition. Neuron (2006) 1.98
Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy. Proc Natl Acad Sci U S A (2011) 1.98
Insular hypocretin transmission regulates nicotine reward. Proc Natl Acad Sci U S A (2008) 1.94
MicroRNAs in neuronal function and dysfunction. Trends Neurosci (2012) 1.94
Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo. J Neurosci (2007) 1.93
Considerations when using the significance analysis of microarrays (SAM) algorithm. BMC Bioinformatics (2005) 1.89
Spinal cord stimulation restores locomotion in animal models of Parkinson's disease. Science (2009) 1.88
Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activity. Mol Pharmacol (2010) 1.86
Human muscle gene expression responses to endurance training provide a novel perspective on Duchenne muscular dystrophy. FASEB J (2005) 1.85
Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics. Proc Natl Acad Sci U S A (2008) 1.85
The utility of LNA in microRNA-based cancer diagnostics and therapeutics. Semin Cancer Biol (2008) 1.84
Elimination of the vesicular acetylcholine transporter in the striatum reveals regulation of behaviour by cholinergic-glutamatergic co-transmission. PLoS Biol (2011) 1.84
N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity. Neuropsychopharmacology (2007) 1.83
Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization. Cancer Res (2005) 1.80
A small molecule enhances RNA interference and promotes microRNA processing. Nat Biotechnol (2008) 1.80
Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutant. Proc Natl Acad Sci U S A (2004) 1.78
Dopaminergic control of sleep-wake states. J Neurosci (2006) 1.77
MicroRNAs in liver disease. Gastroenterology (2012) 1.76
Amygdala-dependent fear is regulated by Oprl1 in mice and humans with PTSD. Sci Transl Med (2013) 1.74